» Authors » Ryosuke Tsuruta

Ryosuke Tsuruta

Explore the profile of Ryosuke Tsuruta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 129
Citations 1914
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaneko T, Fujita M, Tsuruta R
J Toxicol Sci . 2025 Feb; 50(2):69-73. PMID: 39894536
Acute carbon monoxide poisoning (ACOP) is a cause of accidental or deliberate deaths worldwide. Subsequent complications, particularly delayed neurological sequelae (DNS), are preventable and treatable based on their pathophysiology. Hyperbaric...
2.
Koga Y, Fujita M, Kaneda K, Tsuruta R
Resuscitation . 2024 Nov; 204:110401. PMID: 39547785
No abstract available.
3.
Kaneda K, Inoue T, Koga Y, Yagi T, Todani M, Nakahara T, et al.
Cureus . 2024 Aug; 16(7):e64877. PMID: 39156339
Background: Evidence on the efficacy of mamushi antivenom serum is limited. Objective: To investigate the effectiveness of mamushi () antivenom serum. Methods: The Observational Research Of the Clinical course after...
4.
Koga Y, Fujita M, Yagi T, Todani M, Nakahara T, Kaneda K, et al.
Cureus . 2024 Jun; 16(5):e59926. PMID: 38854252
Aim: To examine the preference for advanced airway management (AAM) or intravenous adrenaline administration (IVAd) provided by emergency medical services (EMS) for out-of-hospital cardiac arrest (OHCA) with shockable or nonshockable...
5.
Yagi T, Kawano R, Tomokage T, Ayata R, Koga Y, Kaneda K, et al.
Acute Med Surg . 2024 Apr; 11(1):e954. PMID: 38655507
Background: Factor Xa inhibitors are direct oral anticoagulants that are extremely useful in clinical applications, safe, and do not require dose adjustment. It is desirable to be able to monitor...
6.
Ayata R, Fujita M, Harada K, Esaki Y, Koga Y, Hisamoto Y, et al.
J Toxicol Sci . 2023 Dec; 48(12):641-644. PMID: 38044125
Guanfacine hydrochloride extended-release (GXR) is used to treat attention deficit hyperactivity disorder. It is a selective α2A-adrenorecepor agonist that was reported to cause QT prolongation and hypotension in the event...
7.
Matsuoka T, Fujishima S, Sasaki J, Gando S, Saitoh D, Kushimoto S, et al.
Shock . 2023 Nov; 61(1):89-96. PMID: 38010069
Background: Although coagulopathy is often observed in acute respiratory distress syndrome (ARDS), its clinical impact remains poorly understood. Objectives: This study aimed to clarify the coagulopathy parameters that are clinically...
8.
Shin M, Fujita M, Hifumi T, Koga Y, Yagi T, Nakahara T, et al.
Acute Med Surg . 2023 Oct; 10(1):e897. PMID: 37841965
Aim: To determine whether the rewarming rate is associated with neurological outcomes in patients with post-cardiac arrest syndrome treated with targeted temperature management (TTM) at 34°C. Methods: We conducted a...
9.
Inoue T, Kaneda K, Ise N, Koga Y, Yagi T, Todani M, et al.
Acute Med Surg . 2023 Sep; 10(1):e892. PMID: 37753227
Aim: To determine whether dispatcher-provided cardiopulmonary resuscitation (CPR) instructions improve the outcomes of out-of-hospital cardiac arrest (OHCA). Methods: Cases registered in the Japanese Association for Acute Medicine Out-of-Hospital Cardiac Arrest...
10.
Fujita M, Oda Y, Kaneda K, Kaneko T, Suehiro E, Dohi K, et al.
PLoS One . 2023 May; 18(5):e0285525. PMID: 37155613
Background: The purpose of this study was to examine whether the temperature difference between the jugular bulb and pulmonary artery (ΔTjb-pa) is associated with the neurological outcome of patients with...